CFRX Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (5 gruod. 2023 @ 22:31):

Stats
Dzisiejszy wolumen	910 216
Średni wolumen	262 784
Kapitalizacja rynkowa	371 901
EPS	$-0.500 ( Q3 \| 2023-11-14 )
Następna data zysków	( $0 ) 2024-08-12
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.00462 (Sector) 42.63 (Industry) 24.32
ATR14	$0.0290 (82.98%)

AADI 3.55%

ABCL -3.79%

ABCM 0.04%

ABEO -5.02%

ABIO -0.29%

ABOS -3.03%

ABSI 0.66%

ABUS 0.66%

ABVX 2.61%

ACAD 3.79%

ACER -17.95%

ACET 9.49%

ACGN 1.29%

ACHL 0.22%

ACHV -4.83%

ACIU 2.47%

ACLX -0.09%

ACRV -5.30%

ACST -0.31%

ACXP -2.15%

ADAG 0.69%

ADAP -1.06%

ADGI 0.87%

ADIL 2.68%

ADMA 0.09%

ADPT 1.54%

ADTX -2.08%

ADVM 1.63%

ADXN -5.75%

AEON -7.34%

AEZS -1.10%

AFMD 1.02%

AGEN 4.60%

AGIO 0.02%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA -0.69%

AKRO 2.80%

AKTX -1.08%

AKUS 0.00%

ALBO 0.00%

ALDX -5.46%

ALEC 0.44%

ALGS -4.88%

ALKS -1.28%

ALLK 8.11%

ALLO 2.35%

ALLR -28.40%

ALNA 3.16%

ALNY 34.52%

ALPN 0.02%

ALPX 0.00%

ALRN -1.60%

ALT 11.39%

ALVR 4.92%

ALXN 0.00%

ALXO -0.15%

ALZN -7.26%

AMRN 2.72%

AMTI -3.13%

ANAB 0.21%

ANEB -1.49%

ANGN 0.00%

ANIX -0.79%

ANL 0.29%

ANNX -4.22%

ANPC -3.15%

APGE 2.63%

APGN 8.48%

APGNW 30.65%

APLM 9.95%

APLS 0.92%

APLT 1.76%

APM 1.73%

APOP 0.38%

APRE 3.24%

APTO -2.37%

APTX 3.17%

APVO 1.15%

ARAV -13.39%

ARCT -0.44%

ARDS 2.49%

ARDX 1.46%

ARGX 11.69%

ARNA 0.00%

ARPO -0.90%

ARQT 4.59%

ARTL -2.71%

ARTLW 0.00%

ARVN -0.99%

ARWR 6.82%

ASLN -2.99%

ASMB 0.38%

ASND 1.20%

ATAI 4.48%

ATHA 1.28%

ATHE 2.27%

ATHX -33.50%

ATNF 2.05%

ATOS -5.31%

ATRA 0.67%

ATXI 9.52%

ATXS -2.65%

AUPH 2.35%

AURA -1.25%

AUTL -2.87%

AVBP -0.78%

AVEO 0.00%

AVIR 1.45%

AVRO -1.41%

AVTE -3.85%

AVTX 2.99%

AVXL 3.19%

AXLA 0.00%

AXSM 2.76%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO -15.94%

BCAB 3.31%

BCDA -5.67%

BCDAW -39.75%

BCEL 0.00%

BCLI 2.70%

BCRX -2.34%

BCTX -7.44%

BCTXW -18.26%

BCYC 0.10%

BDRX -15.63%

BDTX 0.83%

BEAM 8.24%

BFRA -2.91%

BGNE 1.95%

BIOR 1.50%

BIVI 0.96%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX 3.39%

BLTE 0.27%

BLU 0.03%

BLUE 13.45%

BMEA 5.51%

BMRN 1.62%

BNOX 2.99%

BNTC 4.80%

BNTX 2.33%

BOLD 13.42%

BOLT -1.45%

BPMC 1.79%

BPTH 0.88%

BPTS -13.47%

BRNS 0.00%

BRTX 1.72%

BTAI 4.39%

BTTX 0.00%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI -1.78%

CABA -1.53%

CADL 1.82%

CALA 0.00%

CALC -1.87%

CALT 1.83%

CAPR 1.91%

CARA 22.71%

CARM 9.80%

CASI 7.65%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS -4.40%

CCCC 11.08%

CCXI 0.00%

CDAK 0.00%

CDIO -0.17%

CDIOW 36.86%

CDMO -4.38%

CDMOP 0.04%

CDT -7.05%

CDTTW -23.91%

CDTX -2.84%

CDXC -6.59%

CDXS 2.04%

CELC 4.58%

CELU 0.66%

CELUW 11.18%

CERC -1.68%

CERE -0.55%

CERO 2.09%

CEROW -22.90%

CFRX -27.95%

CGEM -0.34%

CGEN -5.08%

CGON 1.50%

CGTX -2.63%

CHMA -6.00%

CHRS -2.40%

CINC 0.00%

CING 4.73%

CINGW 73.79%

CKPT 15.56%

CLBS -16.75%

CLDX 2.55%

CLGN 6.22%

CLLS 1.06%

CLNN -3.46%

CLNNW -33.25%

CLRB 0.00%

CLSD 0.00%

CLSN -0.68%

CLVS 0.00%

CMMB 8.57%

CMND -7.59%

CMPI 0.00%

CMPX 0.91%

CMRA 0.00%

CMRAW 33.33%

CMRX 1.85%

CNCE 0.00%

CNSP 12.63%

CNST 0.00%

CNTA -2.31%

CNTB -6.25%

CNTX 0.93%

COCP -1.88%

COEPW 0.00%

COGT 1.14%

CORT 1.83%

COYA -2.48%

CPRX -1.28%

CRBP 2.42%

CRBU 8.72%

CRDF -3.67%

CRGX 4.50%

CRIS 3.02%

CRNX 0.18%

CRSP 3.02%

CRTX 2.63%

CRVO 0.40%

CRVS 2.81%

CSBR -1.20%

CTCX -7.84%

CTIC 0.06%

CTMX 3.10%

CTNM 3.23%

CTXR 4.68%

CUE 8.89%

CVAC 6.44%

CVKD 6.24%

CWBR 0.00%

CYAD -12.96%

CYCC -5.01%

CYCCP 4.03%

CYCN 6.69%

CYT -2.27%

CYTK 0.71%

CYTO 2.61%

DARE 1.96%

DAWN -1.10%

DBTX -0.81%

DBVT -1.80%

DFFN 10.28%

DICE 0.06%

DMAC 2.78%

DNLI 1.24%

DNTH -0.04%

DOMH -2.63%

DRMA 12.50%

DRMAW -1.25%

DRNA 0.00%

DRTS 1.62%

DRTSW 0.00%

DRUG -3.77%

DSGN -0.59%

DTIL 0.85%

DYAI -9.66%

EARS -1.77%

EDIT -0.59%

EDSA -0.11%

EFTR -75.81%

EFTRW -96.33%

EIGR -9.21%

ELAB 0.86%

ELDN -4.40%

ELEV -4.30%

ELOX 0.00%

ELTX 6.89%

ELVN 1.87%

ELYM -8.69%

ENGN -9.67%

ENGNW -7.87%

ENLV 3.68%

ENOB 1.79%

ENSC 4.98%

ENTA 2.43%

ENTO -2.13%

ENTX 1.98%

ENVB 9.19%

EPIX -1.02%

EPRX 0.57%

EPZM 0.00%

EQ 2.52%

EQRX -2.09%

EQRXW 0.00%

ERAS 2.37%

ERNA -4.64%

ERYP 1.30%

ESLA -0.50%

ESLAW 0.00%

ETNB -0.82%

ETON -0.60%

ETTX 0.00%

EVAX -5.28%

EVGN -2.18%

EVLO 0.00%

EWTX -1.99%

EXAI -2.78%

EXEL 0.54%

EYEG 0.11%

EYEN 2.28%

EYPT 0.59%

FATE 2.13%

FBIO -3.95%

FBIOP 0.59%

FBLG 5.49%

FBRX 0.27%

FDMT 1.35%

FENC -1.09%

FGEN 6.19%

FHTX 0.38%

FIXX 0.77%

FMTX 0.00%

FNCH -6.77%

FOLD -0.89%

FREQ 4.76%

FRLN 0.15%

FRTX -4.51%

FSTX 0.00%

FTRE -0.65%

FULC -5.09%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT -8.97%

GANX 0.00%

GBIO 1.45%

GBT 0.01%

GDTC 5.61%

GERN -1.29%

GHRS 0.42%

GLMD -1.83%

GLPG 1.67%

GLSI -4.73%

GLTO 5.51%

GLUE 4.96%

GLYC 3.61%

GMAB -0.81%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT 1.29%

GNLX 10.68%

GNPX 0.00%

GNTA 7.74%

GOSS 27.09%

GOVX 30.04%

GOVXW 49.24%

GPCR -4.15%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS 4.76%

GRTX 40.48%

GTHX -10.48%

GUTS 5.77%

GXGXW 41.67%

GYRE -3.28%

HALO 0.99%

HARP 0.09%

HCWB 10.69%

HEPA 5.42%

HGEN -84.62%

HILS 5.66%

HLVX 2.75%

HOOK -1.07%

HOTH 0.67%

HOWL -9.38%

HRMY -0.10%

HRTX -1.55%

HSTO 0.00%

HUMA -1.35%

HUMAW 5.19%

IBRX 1.10%

ICCC -0.22%

ICPT 0.21%

ICU 10.12%

ICUCW 14.68%

ICVX -0.91%

IDRA -23.04%

IDYA 0.03%

IFRX 8.44%

IGMS 0.00%

IKNA -2.33%

IKT -5.00%

IMAB 2.38%

IMCR -0.28%

IMGN 0.02%

IMGO 0.00%

IMMP -2.92%

IMMX 11.76%

IMNM -4.02%

IMNN -4.46%

IMPL -27.27%

IMRA 15.96%

IMRN 12.11%

IMRX 4.20%

IMTX -1.37%

IMTXW -14.50%

IMUX -0.90%

IMV 0.00%

IMVT 0.18%

INAB -0.84%

INBX 2.18%

INCY 0.84%

INDP -1.33%

INFI -52.38%

INKT -1.62%

INM 9.72%

INMB 1.62%

INO -1.61%

INSM 0.65%

INTS 4.74%

INVA 0.63%

INZY 0.67%

IOBT 0.00%

IONS 6.81%

IOVA 1.87%

IPA -1.92%

IPHA -5.16%

IPSC -6.29%

IRON 1.81%

ISEE 0.38%

ITOS 0.61%

ITRM -5.65%

IVA -0.71%

IVVD 2.42%

JAGX -3.32%

JANX 5.52%

JAZZ 1.72%

JNCE 0.00%

JSPR 1.72%

JSPRW 4.71%

JUNS 0.00%

JUNSW 0.00%

KA 13.13%

KALV -0.17%

KDNY 0.22%

KMPH -0.34%

KNSA 1.40%

KNTE -0.38%

KOD 3.41%

KPRX 9.68%

KPTI 12.76%

KRBP -0.40%

KRON -6.48%

KROS 0.09%

KRRO -0.76%

KRTX 0.03%

KRYS 1.97%

KTRA 6.15%

KTTA 4.85%

KTTAW -5.17%

KURA 0.67%

KYMR -1.69%

KYTX 2.07%

KZIA -15.51%

KZR 1.12%

LABP 0.57%

LBPH 0.05%

LBPS 0.00%

LBPSW 14.81%

LEGN 1.13%

LENZ -1.52%

LEXX -1.49%

LEXXW -0.19%

LGND 0.72%

LGNDV 0.00%

LGVN -12.73%

LIAN -8.28%

LIFE 2.70%

LIPO 10.88%

LIXT -1.57%

LIXTW 0.00%

LJPC -0.32%

LMNL 0.12%

LOGC 1.27%

LPCN 3.56%

LPTX -2.08%

LQDA 3.28%

LRMR -10.33%

LSTA -3.26%

LTRN -5.78%

LUMO 1.79%

LVTX 0.27%

LXEO 4.94%

LXRX -2.16%

LYEL 3.41%

LYRA -2.78%

MACK 0.10%

MBIO 2.70%

MBRX -3.48%

MCRB -2.19%

MDGL 2.00%

MDNA -13.16%

MDWD 7.88%

MDXG -1.02%

MEIP -2.80%

MESO -3.28%

MGNX 2.97%

MGTA -7.74%

MGTX -3.18%

MGX 0.56%

MIRM 8.74%

MIRO 0.59%

MIST 0.72%

MITO 0.00%

MLEC -5.36%

MLECW 90.24%

MLND -5.36%

MLTX 0.73%

MLYS 4.90%

MNKD 6.26%

MNMD 0.27%

MNOV 0.00%

MNPR 15.76%

MOLN -25.10%

MOR -0.11%

MORF 10.26%

MREO -5.53%

MRKR 9.03%

MRNA 2.70%

MRNS 3.01%

MRSN 3.76%

MRTX -0.17%

MRUS 3.77%

MRVI -2.35%

MTCR -1.29%

MTEM -4.59%

MTP -18.50%

MURA -0.62%

MYMD -4.12%

NAMS 8.93%

NAMSW 26.87%

NAUT -8.57%

NBRV 0.71%

NBSE -1.56%

NBTX 4.81%

NCNA -0.34%

NERV -5.52%

NEXI -2.44%

NGM -1.28%

NGNE 2.39%

NKGN 0.00%

NKGNW 8.00%

NKTR 0.86%

NKTX 1.82%

NLSP -5.16%

NLSPW 28.30%

NMRA 0.00%

NMTR -42.97%

NOVN -24.84%

NRBO 0.49%

NRIX -1.27%

NRSN -3.99%

NRSNW 0.00%

NRXP 0.75%

NRXPW 0.00%

NRXS -0.78%

NTBL 0.36%

NTEC -12.45%

NTHI 0.00%

NTLA 3.22%

NTRBW 0.00%

NUVL 1.72%

NVAX 0.14%

NVCT 2.13%

NVIV -34.28%

NXTC 3.70%

NYMX -0.05%

OABI 1.75%

OABIW -3.65%

OBIO 9.02%

OBSV 0.00%

OCEA 7.75%

OCGN -5.26%

OCS 1.37%

OCUL 4.48%

OCUP 1.27%

ODT -4.27%

OKYO -1.63%

OLMA 2.15%

OMER 2.90%

OMGA -0.41%

ONCO -6.85%

ONCR -3.08%

ONCS 31.87%

ONCT -1.85%

ONCY 0.00%

ONTX -0.47%

ONVO -2.28%

OPNT 0.00%

OPT -4.93%

ORGS -3.25%

ORIC -1.11%

ORMP -3.04%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -2.62%

OVID 1.28%

OYST 0.00%

PALI -3.95%

PASG 0.00%

PBLA -4.76%

PBM -4.74%

PBYI -2.34%

PCSA 0.51%

PCVX 1.12%

PDSB 8.33%

PEPG 4.57%

PGEN 4.55%

PHAR 13.76%

PHAS 0.00%

PHAT -2.26%

PHIO 3.65%

PHIOW 36.47%

PHVS -4.62%

PHXM -5.20%

PIRS -5.56%

PKBO 0.00%

PKBOW 999 900.00%

PLRX 3.28%

PLUR -0.44%

PMN -0.63%

PMVP 4.64%

PNT 0.16%

PPBT 5.78%

PRAX -2.61%

PRDS 0.93%

PRLD 2.88%

PROG -3.47%

PROK -7.60%

PRQR -3.51%

PRTA 0.56%

PRTC -6.90%

PRTG -0.04%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -11.11%

PSTX -1.08%

PTCT -2.05%

PTE -0.82%

PTGX -0.78%

PTIXW -5.10%

PULM -2.53%

PXMD 0.00%

PYPD -1.97%

PYXS -5.34%

QLGN -8.10%

QNCX 0.71%

QNRX 1.44%

QSI 0.84%

QSIAW 1.20%

QTTB -0.71%

QURE -1.09%

RAIN -1.63%

RANI -0.96%

RAPT 3.18%

RARE -0.45%

RCKT 7.03%

REGN 1.02%

RENB 1.27%

REPL 3.06%

RETA 0.02%

REUN -0.89%

REVB 13.74%

REVBU 3.46%

REVBW 50.29%

RGLS -18.33%

RGNX 6.41%

RIGL 0.65%

RLAY -0.58%

RLMD -0.99%

RLYB 5.48%

RNA 1.69%

RNAC 1.05%

RNAZ 5.27%

RNXT 4.09%

ROIV 2.06%

ROIVW 4.56%

RPHM 0.00%

RPRX 0.74%

RPTX 0.28%

RUBY 2.70%

RVLP -32.05%

RVMD 0.76%

RVMDW 17.51%

RVNC -3.38%

RVPH 2.40%

RVPHW 1.92%

RXDX 0.09%

RXRX 5.54%

RYTM 1.58%

RYZB 0.02%

RZLT 7.85%

SABS 4.23%

SABSW -35.81%

SAGE 3.86%

SANA 0.54%

SAVA -1.10%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI -6.67%

SCPH 1.24%

SCPS 0.00%

SEEL -2.49%

SEER 1.76%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO 5.62%

SGMT 6.87%

SGTX -2.56%

SIOX 22.63%

SLDB 2.48%

SLGL 0.59%

SLN 3.61%

SLNO -2.60%

SLRX -3.97%

SLS -0.82%

SMMT 0.88%

SNDX -1.25%

SNGX -2.31%

SNPX 5.67%

SONN -6.53%

SPPI -0.49%

SPRB 5.39%

SPRC -2.42%

SPRO -2.92%

SRNE 15.79%

SRPT 1.95%

SRRA 0.00%

SRRK -0.47%

SRZN 5.26%

STAB 0.00%

STOK 0.70%

STRO -4.95%

STSA 0.00%

STTK -9.50%

SURF -0.93%

SVRA -5.67%

SWTX -0.17%

SYBX 2.01%

SYRS 4.12%

TALS -0.73%

TARA -1.33%

TARS 1.36%

TBPH 0.23%

TCBP -8.11%

TCDA 0.00%

TCON -1.60%

TCRR 0.00%

TCRT -3.84%

TCRX 2.92%

TECH 1.13%

TENX 9.03%

TERN 4.01%

TFFP 9.20%

TGTX 4.31%

THRX 0.12%

TIL -3.68%

TLC 0.00%

TLSA 14.49%

TNGX 0.50%

TNXP -8.46%

TNYA -0.96%

TPST 2.96%

TRDA -4.11%

TRVI -2.22%

TRVN -13.99%

TSHA -10.14%

TSVT 3.76%

TTNP -14.84%

TVTX 6.57%

TYRA 0.35%

UBX 0.36%

UNCY 7.44%

URGN 5.81%

UTHR 0.92%

VACC 11.36%

VALN 12.99%

VAXX -10.53%

VBIV 3.44%

VBLT -8.77%

VCEL 2.64%

VCNX -0.49%

VCYT 1.77%

VERA -2.79%

VERU 9.04%

VERV -0.19%

VIGL 0.52%

VINC -1.38%

VIR 0.22%

VIRI -1.85%

VIRX -5.63%

VKTX -1.18%

VLON -13.04%

VNDA -2.29%

VOR 4.20%

VRCA -4.56%

VRDN 5.09%

VRNA 4.60%

VRPX -4.95%

VRTX 1.33%

VSTM -1.90%

VTGN -3.58%

VTVT 0.00%

VTYX -0.80%

VXRT 5.82%

VYGR -0.43%

VYNE -4.95%

VYNT 7.78%

WINT 7.90%

WVE -0.76%

XBIO -5.83%

XBIT -12.02%

XCUR -3.35%

XENE -0.21%

XERS 0.00%

XFOR 0.00%

XLO 2.47%

XLRN 0.00%

XNCR 1.46%

XOMA 5.64%

XOMAO -0.20%

XOMAP -0.76%

XRTX -2.38%

YMAB 0.83%

ZGNX 0.00%

ZIOP -0.88%

ZLAB 0.97%

ZNTL -3.16%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2023-02-14	Messinger Michael	Buy	25 000	Options (Right to Buy)
2022-05-17	Barlow Jane F	Buy	42 000	Options (Right to Buy)
2022-05-17	Sucoff Cary	Buy	42 000	Options (Right to Buy)
2022-05-17	Otto Michael J.	Buy	42 000	Options (Right to Buy)
2022-05-17	Low David N.	Buy	42 000	Options (Right to Buy)

INSIDER POWER
100.00
Last 55 transactions
Buy: 2 642 000 \| Sell: 9 700 000

Wolumen Korelacja

Długi: -0.02 (neutral)

Krótki: -0.53 (weak negative)

Signal:(32.31) Neutral

ContraFect Corp Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

ContraFect Corp Korelacja - Waluta/Towar

0.96
( very strong )

0.91
( very strong )

-0.89
( strong negative )

0.96
( very strong )

0.97
( very strong )

-0.59
( weak negative )

ContraFect Corp Finanse

Annual	2022
Przychody:	$0
Zysk brutto:	$0 (0.00 %)
EPS:	$-126.01

FY	2022
Przychody:	$0
Zysk brutto:	$0 (0.00 %)
EPS:	$-126.01

FY	2021
Przychody:	$0.00
Zysk brutto:	$0.00 (0.00 %)
EPS:	$-0.891

FY	2020
Przychody:	$0.00
Zysk brutto:	$0.00 (0.00 %)
EPS:	$-1.240

Financial Reports:

No articles found.

ContraFect Corp Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

ContraFect Corp

ContraFect Corporation, a clinical-stage biotechnology company, discovers and develops therapeutic protein and antibody products for the treatment of life-threatening and drug-resistant infectious diseases in the United States. Its lead program includes Exebacase, a lysin, which is in Phase III clinical trials for the treatment of staphylococcus aureus bacteremia. The company also develops CF-296, an engineered lysin, used for treatment of the invasive infections caused by staphylococcus aureus including biofilm-related infections in prosthetic joints and indwelling devices and osteomyelitis; and CF-370, an investigational anti-bacterial therapeutic candidate, which is in Phase 1 clinical trials to treat pseudomonas aeruginosa infections, such as ventilator associated pneumonia, blood stream infections, complicated urinary tract infections, and surgery carry infections. It also initiated an expanded access program to provide Exebacase for the treatment of persistent bacteremia caused by methicillin-resistant staphylococcus aureus in COVID-19 patients. The company has a license agreement with The Rockefeller University to identify novel lysin therapeutic candidates targeting gram-negative pathogens. ContraFect Corporation was incorporated in 2008 and is headquartered in Yonkers, New York.